


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+32.76%
+7.37%
-8.16%
+30.14%
CVKD
Cadrenal Therapeutics
$4.96

Login to see Cadrenal Therapeutics (CVKD) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow
CVKD Price Performance
$6.53 (-24.04%)
$8 (-38.00%)
$6.93 (-28.43%)
$13.86 (-64.21%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
CVKD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CVKD Street Sentiment is bullish and have negative views on the near-term outlook
CVKD has Extreme risk level

Sentiments overview associated with events and the stock performance
DWTX
Dogwood Therapeutics Inc.
1.69
+1.20%
AKTX
Akari Therapeutics plc
16.43
-25.49%
What is CVKD current stock price?
What is CVKD current Stock IQ?
What is CVKD RSI signal right now?
What is CVKD analyst price target and upside potential?
What do analysts say about CVKD stock?
What is CVKD momentum trend right now?
What are CVKD stock strengths?
What is CVKD Risk Level?
Should I buy CVKD stock right now?
Is CVKD a Strong Buy right now?
What is CVKD market cap and volume?
What factors influence CVKD's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
CVKD
Cadrenal Therapeutics
Current Price
$4.96
DWTX
Dogwood Therapeutics Inc.
1.69
+1.20%
AKTX
Akari Therapeutics plc
16.43
-25.49%

CVKD Price Performance
$6.53 (-24.04%)
$8 (-38.00%)
$6.93 (-28.43%)
$13.86 (-64.21%)
CVKD Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
CVKD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CVKD Street Sentiment is bullish and have negative views on the near-term outlook
CVKD has Extreme risk level

CVKD Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
CVKD Trading Signals
CVKD is showing high volatility with an intraday swing of 6.88% (High: $5.13, Low: $4.80). This signals potential opportunities.
CVKD showing early bearish trend, price below MA20 (5.43) and MA20 below MA50 (5.83)
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CVKD Stock trends
CVKD Stock performance
CVKD Stock analysis
CVKD investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.